Breakthrough Device status for novel blood filtering immunotherapy – PMLiVE
PMLiVE |
Breakthrough Device status for novel blood filtering immunotherapy
PMLiVE This year has seen the FDA grant a flurry of Breakthrough Device Designations, and the latest is from Immunicom and its proprietary novel blood filtering technology called 'Immunopheresis'. The San Diego-based firm's lead therapy focuses on removing … |
